机构：[1]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[2]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[3]Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
第一作者机构：[1]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China[2]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China[3]Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
通讯作者：
通讯机构：[1]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China[2]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China[3]Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
推荐引用方式(GB/T 7714)：
Wang Ran Lin,Li Tao,Lv Jiahua,et al.Clinical benefit of EGFR-TKIs plus radiotherapy for treating EGFR-mutated metastatic non-small cell lung cancer.[J].JOURNAL OF CLINICAL ONCOLOGY.2019,37(15):doi:10.1200/JCO.2019.37.15_suppl.e20694.
APA：
Wang, Ran Lin,Li, Tao,Lv, Jiahua,Sun, Chang&Shi, Qiuling.(2019).Clinical benefit of EGFR-TKIs plus radiotherapy for treating EGFR-mutated metastatic non-small cell lung cancer..JOURNAL OF CLINICAL ONCOLOGY,37,(15)
MLA：
Wang, Ran Lin,et al."Clinical benefit of EGFR-TKIs plus radiotherapy for treating EGFR-mutated metastatic non-small cell lung cancer.".JOURNAL OF CLINICAL ONCOLOGY 37..15(2019)
医学